Drug-Related Problems and Sick Day Management Considerations for Medications that Contribute to the Risk of Acute Kidney Injury.

acute kidney injury chronic kidney disease descriptive study medication review medication therapy management sick day management

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
07 Jan 2024
Historique:
received: 28 11 2023
revised: 19 12 2023
accepted: 28 12 2023
medline: 23 1 2024
pubmed: 23 1 2024
entrez: 23 1 2024
Statut: epublish

Résumé

Medication use during acute illness increases the risk of experiencing drug related problems (DRPs), including acute kidney injuries. It is recommended that potentially nephrotoxic medications are withheld during acute illness, including sulfonylureas, angiotensin converting enzyme inhibitors, diuretics, metformin, angiotensin receptor blockers, non-steroidal anti-inflammatories and sodium glucose co-transporter 2 inhibitors (SADMANS). It is unknown if Australian pharmacists currently provide sick day medication management advice regarding SADMANS medications. Hence, we aimed to identify current DRPs and the recommendations made during residential medication management reviews (RMMRs), especially with SADMANS medications. A retrospective review of 408 RMMRs was conducted. DRPs and pharmacist recommendations were classified according to a modified DOCUMENT system. General practitioners' (GP) recommendations were also categorised. Over 97% of residents experienced at least one DRP. Common problems for non-SADMANS medications were "toxicity or adverse drug reaction", "drug selection" and "over/underdosing" and those for SADMANS medications included "toxicity or adverse drug reaction", "monitoring" and "drug selection". GPs agreed with pharmacist recommendations approximately 40% of the time. No pharmacists provided sick day medication management advice for SADMANS medications. DRPs remain highly prevalent in aged care facilities. Medication reviews effectively identify and resolve DRPs approximately 40% of the time, but do not currently minimise the risk associated with using SADMANS medications during sick days, which is a potential area of improvement.

Sections du résumé

BACKGROUND BACKGROUND
Medication use during acute illness increases the risk of experiencing drug related problems (DRPs), including acute kidney injuries. It is recommended that potentially nephrotoxic medications are withheld during acute illness, including sulfonylureas, angiotensin converting enzyme inhibitors, diuretics, metformin, angiotensin receptor blockers, non-steroidal anti-inflammatories and sodium glucose co-transporter 2 inhibitors (SADMANS). It is unknown if Australian pharmacists currently provide sick day medication management advice regarding SADMANS medications. Hence, we aimed to identify current DRPs and the recommendations made during residential medication management reviews (RMMRs), especially with SADMANS medications.
METHODS METHODS
A retrospective review of 408 RMMRs was conducted. DRPs and pharmacist recommendations were classified according to a modified DOCUMENT system. General practitioners' (GP) recommendations were also categorised.
RESULTS RESULTS
Over 97% of residents experienced at least one DRP. Common problems for non-SADMANS medications were "toxicity or adverse drug reaction", "drug selection" and "over/underdosing" and those for SADMANS medications included "toxicity or adverse drug reaction", "monitoring" and "drug selection". GPs agreed with pharmacist recommendations approximately 40% of the time. No pharmacists provided sick day medication management advice for SADMANS medications.
CONCLUSION CONCLUSIONS
DRPs remain highly prevalent in aged care facilities. Medication reviews effectively identify and resolve DRPs approximately 40% of the time, but do not currently minimise the risk associated with using SADMANS medications during sick days, which is a potential area of improvement.

Identifiants

pubmed: 38256477
pii: jcm13020343
doi: 10.3390/jcm13020343
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Mimi Truong (M)

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.

Wubshet Tesfaye (W)

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.

Kamal Sud (K)

Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.
Nepean Kidney Research Centre, Department of Renal Medicine, Nepean Hospital, Nepean and Blue Mountains Local Health District, Kingswood 2747, Australia.

Connie Van (C)

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.

Shrey Seth (S)

Manipal Academy of Higher Education (MAHE), The University of Sydney, Sydney 2006, Australia.

Nerida Croker (N)

Meditrax, Drummoyne 2047, Australia.

Ronald Lynel Castelino (RL)

School of Pharmacy, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia.
Pharmacy Department, Blacktown Hospital, WSLHD, Blacktown 2148, Australia.

Classifications MeSH